3/10/26 21:30 | 3/10/26 | MNKD | Mannkind Corp | DE | Health | Drug | Pharmaceutical Preparations | Castagna Michael | CT | DO | CEO | P | 259 | 2.59 | 0 | 100 | 4 | 2,577 | D | | | | | | | | | | | | | | |
3/10/26 20:58 | 3/6/26 | NAMS | Newamsterdam Pharma Co N.V. | P7 | Health | Drug | Pharmaceutical Preparations | Lange Louis G | P7 | D | | S.d | -829 | 29.41 | 0 | -28 | -34 | 55 | M | | | | | | | | | | | | | | |
3/10/26 19:36 | 3/1/26 | WHWK | Whitehawk Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lennon David James | NJ | DO | CEO | M.d | 0 | 0.00 | 0 | 16 | 57 | 45 | D | | | | | | | | | | | | | | |
3/10/26 19:36 | 3/2/26 | WHWK | Whitehawk Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lennon David James | NJ | DO | CEO | S.d | -17 | 3.31 | 0 | -5 | -10 | 45 | D | | | | | | | | | | | | | | |
3/10/26 19:36 | 3/1/26 | WHWK | Whitehawk Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Giacobello Scott M. | NJ | O | CFO | M.d | 0 | 0.00 | 0 | 7 | 32 | 28 | D | | | | | | | | | | | | | | |
3/10/26 19:36 | 3/2/26 | WHWK | Whitehawk Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Giacobello Scott M. | NJ | O | CFO | S.d | -9 | 3.31 | 0 | -3 | -8 | 28 | D | | | | | | | | | | | | | | |
3/10/26 19:35 | 3/1/26 | WHWK | Whitehawk Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ball Bryan | NJ | O | See rema | M.d | 0 | 0.00 | 0 | 5 | 2 | 206 | D | | | | | | | | | | | | | | |
3/10/26 19:35 | 3/2/26 | WHWK | Whitehawk Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ball Bryan | NJ | O | See rema | S.d | -6 | 3.31 | 0 | -2 | -1 | 206 | D | | | | | | | | | | | | | | |
3/10/26 19:04 | 3/6/26 | VTRS | Viatris Inc | DE | Health | Drug | Pharmaceutical Preparations | Le Goff Corinne | PA | O | Chief Co | M.d | 0 | 0.00 | 0 | 46 | 126 | 83 | D | | | | | | | | | | | | | | |
3/10/26 19:04 | 3/6/26 | VTRS | Viatris Inc | DE | Health | Drug | Pharmaceutical Preparations | Mistras Theodora | PA | O | CFO | M.d | 0 | 0.00 | 0 | 44 | 163 | 71 | D | | | | | | | | | | | | | | |
3/10/26 19:03 | 3/6/26 | VTRS | Viatris Inc | DE | Health | Drug | Pharmaceutical Preparations | Severino Michael | PA | D | | M.d | 0 | 0.00 | 0 | 26 | New | 26 | D | | | | | | | | | | | | | | |
3/10/26 19:03 | 3/6/26 | VTRS | Viatris Inc | DE | Health | Drug | Pharmaceutical Preparations | Parrish Mark W | PA | D | | M.d | 0 | 0.00 | 0 | 25 | 18 | 165 | D | | | | | | | | | | | | | | |
3/10/26 19:03 | 3/6/26 | VTRS | Viatris Inc | DE | Health | Drug | Pharmaceutical Preparations | Mark Richard A | PA | D | | M.d | 0 | 0.00 | 0 | 25 | 27 | 116 | D | | | | | | | | | | | | | | |
3/10/26 19:03 | 3/6/26 | VTRS | Viatris Inc | DE | Health | Drug | Pharmaceutical Preparations | Campbell Paul | PA | O | See Rema | M.d | 0 | 0.00 | 0 | 29 | 8 | 388 | D | | | | | | | | | | | | | | |
3/10/26 19:03 | 3/6/26 | VTRS | Viatris Inc | DE | Health | Drug | Pharmaceutical Preparations | Smith Scott Andrew | PA | DO | CEO | M.d | 0 | 0.00 | 0 | 131 | 11 | 1,329 | D | | | | | | | | | | | | | | |
3/10/26 19:03 | 3/6/26 | VTRS | Viatris Inc | DE | Health | Drug | Pharmaceutical Preparations | Higgins Melina E | PA | D | | M.d | 0 | 0.00 | 0 | 25 | 13 | 220 | D | | | | | | | | | | | | | | |
3/10/26 19:03 | 8/27/25 | VTRS | Viatris Inc | DE | Health | Drug | Pharmaceutical Preparations | Simmons David S | PA | D | | P.dm | 5 | 10.42 | 0 | 0 | 2 | 25 | M | | | | | | | | | | | | | | |
3/10/26 19:03 | 3/6/26 | VTRS | Viatris Inc | DE | Health | Drug | Pharmaceutical Preparations | Simmons David S | PA | D | | M.d | 0 | 0.00 | 0 | 23 | 999% | 25 | M | | | | | | | | | | | | | | |
3/10/26 19:03 | 3/6/26 | VTRS | Viatris Inc | DE | Health | Drug | Pharmaceutical Preparations | Groothuis Leo Frans | PA | D | | M.d | 0 | 0.00 | 0 | 25 | 64 | 63 | D | | | | | | | | | | | | | | |
3/10/26 19:03 | 3/6/26 | VTRS | Viatris Inc | DE | Health | Drug | Pharmaceutical Preparations | Lyons Dillon Joellen | PA | D | | M.d | 0 | 0.00 | 0 | 25 | 32 | 103 | D | | | | | | | | | | | | | | |
3/10/26 19:03 | 3/6/26 | VTRS | Viatris Inc | DE | Health | Drug | Pharmaceutical Preparations | Kilts James M | PA | D | | M.d | 0 | 0.00 | 0 | 25 | 18 | 161 | D | | | | | | | | | | | | | | |
3/10/26 19:03 | 3/6/26 | VTRS | Viatris Inc | DE | Health | Drug | Pharmaceutical Preparations | Vivaldi Coelho Rogerio | PA | D | | M.d | 0 | 0.00 | 0 | 25 | 114 | 47 | D | | | | | | | | | | | | | | |
3/10/26 19:03 | 3/6/26 | VTRS | Viatris Inc | DE | Health | Drug | Pharmaceutical Preparations | Damelio Frank A | PA | D | | M.d | 0 | 0.00 | 0 | 26 | New | 26 | D | | | | | | | | | | | | | | |
3/10/26 19:03 | 3/6/26 | VTRS | Viatris Inc | DE | Health | Drug | Pharmaceutical Preparations | Cornwell W Don | PA | D | | M.d | 0 | 0.00 | 0 | 25 | 28 | 112 | D | | | | | | | | | | | | | | |
3/10/26 19:03 | 3/6/26 | VTRS | Viatris Inc | DE | Health | Drug | Pharmaceutical Preparations | Finney Elisha W | PA | D | | M.d | 0 | 0.00 | 0 | 25 | 66 | 63 | D | | | | | | | | | | | | | | |
3/10/26 18:47 | 3/6/26 | KALV | Kalvista Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Palleiko Benjamin L | MA | DO | CEO | M.d | 0 | 0.00 | 0 | 16 | 4 | 452 | D | | | | | | | | | | | | | | |
3/10/26 18:47 | 3/9/26 | KALV | Kalvista Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Palleiko Benjamin L | MA | DO | CEO | S.d | -108 | 16.08 | 0 | -7 | -1 | 452 | D | | | | | | | | | | | | | | |
3/10/26 18:20 | 3/10/26 | VKTX | Viking Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Aubuchon Neil William | CA | O | Chief Co | P | 150 | 33.50 | 0 | 4 | New | 4 | D | | | | | | | | | | | | | | |
3/10/26 18:15 | 3/6/26 | ELVN | Enliven Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hohl Benjamin | CO | O | CFO | S | -296 | 29.58 | 0 | -10 | -16 | 51 | D | | | | | | | | | | | | | | |
3/10/26 18:05 | 3/9/26 | CYTK | Cytokinetics Inc | | Health | Drug | Pharmaceutical Preparations | Callos Andrew | CA | O | EVP,Chie | S | -157 | 60.72 | 0 | -3 | -5 | 48 | D | | | | | | | | | | | | | | |
3/10/26 17:48 | 3/9/26 | MLYS | Mineralys Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rodman David Malcom | PA | O | Chief Me | M.d | 35 | 16.00 | 0 | 2 | 3 | 82 | D | | | | | | | | | | | | | | |
3/10/26 17:48 | 3/9/26 | MLYS | Mineralys Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rodman David Malcom | PA | O | Chief Me | S.d | -58 | 26.84 | 0 | -2 | -3 | 82 | D | | | | | | | | | | | | | | |
3/10/26 17:42 | 3/6/26 | NATR | Natures Sunshine Products Inc | UT | Health | Drug | Pharmaceutical Preparations | Brower Nathan G | UT | O | EVP,GC | M | 0 | 0.00 | 0 | 1 | 2 | 53 | D | | | | | | | | | | | | | | |
3/10/26 17:41 | 3/6/26 | NATR | Natures Sunshine Products Inc | UT | Health | Drug | Pharmaceutical Preparations | Herbert Kevin R. | UT | O | EVP,P,No | M | 0 | 0.00 | 0 | 1 | 3 | 51 | D | | | | | | | | | | | | | | |
3/10/26 17:41 | 3/6/26 | NATR | Natures Sunshine Products Inc | UT | Health | Drug | Pharmaceutical Preparations | Jones Leslie Shane | UT | O | EVP,CFO | M | 0 | 0.00 | 0 | 2 | 2 | 122 | D | | | | | | | | | | | | | | |
3/10/26 17:40 | 3/6/26 | NATR | Natures Sunshine Products Inc | UT | Health | Drug | Pharmaceutical Preparations | Lanoy Jonathan David | UT | O | SVP,Chie | M | 0 | 0.00 | 0 | 1 | 2 | 52 | D | | | | | | | | | | | | | | |
3/10/26 17:40 | 3/6/26 | NATR | Natures Sunshine Products Inc | UT | Health | Drug | Pharmaceutical Preparations | Norman Daniel C | UT | O | EVP,P,As | M | 0 | 0.00 | 0 | 2 | 2 | 74 | D | | | | | | | | | | | | | | |
3/10/26 17:39 | 3/6/26 | NATR | Natures Sunshine Products Inc | UT | Health | Drug | Pharmaceutical Preparations | Yates Bryant J | UT | O | EVP,P,Eu | M | 0 | 0.00 | 0 | 1 | 1 | 107 | D | | | | | | | | | | | | | | |
3/10/26 17:33 | 3/6/26 | DYN | Dyne Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Posner Brian S | MA | D | | P | 45 | 15.06 | 0 | 3 | 35 | 12 | D | | | | | | | | | | | | | | |
3/10/26 17:02 | 3/10/26 | EDSA | Edesa Biotech, Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Nijhawan Pardeep | A6 | DOT | CEO | P | 7 | 6.60 | 0 | 1 | 0 | 1,149 | D | | | | | | | | | | | | | | |
3/10/26 16:51 | 3/6/26 | RARE | Ultragenyx Pharmaceutical Inc. | DE | Health | Drug | Pharmaceutical Preparations | Parschauer Karah Herdman | CA | O | EVP,GC | S.m | -208 | 21.87 | 0 | -10 | -12 | 67 | D | | | | | | | | | | | | | | |
3/10/26 16:34 | 3/9/26 | UTHR | United Therapeutics Corp | DE | Health | Drug | Pharmaceutical Preparations | Rothblatt Martine A | MD | DO | CHAIRPER | M.d | 1,387 | 146.03 | 0 | 10 | 2 | 639 | D | | | | | | | | | | | | | | |
3/10/26 16:34 | 3/9/26 | UTHR | United Therapeutics Corp | DE | Health | Drug | Pharmaceutical Preparations | Rothblatt Martine A | MD | DO | CHAIRPER | S.d | -4,921 | 518.03 | 0 | -10 | -1 | 639 | D | | | | | | | | | | | | | | |
3/10/26 16:33 | 3/6/26 | UTHR | United Therapeutics Corp | DE | Health | Drug | Pharmaceutical Preparations | Rothblatt Martine A | MD | DO | CHAIRPER | M.d | 1,387 | 146.03 | 0 | 10 | 2 | 639 | D | | | | | | | | | | | | | | |
3/10/26 16:33 | 3/6/26 | UTHR | United Therapeutics Corp | DE | Health | Drug | Pharmaceutical Preparations | Rothblatt Martine A | MD | DO | CHAIRPER | S.d | -4,538 | 477.67 | 0 | -10 | -1 | 639 | D | | | | | | | | | | | | | | |
3/10/26 16:30 | 3/6/26 | NUVL | Nuvalent, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Porter James Richard | MA | DO | P,CEO | M.d | 836 | 27.85 | 0 | 30 | 10 | 325 | D | | | | | | | | | | | | | | |
3/10/26 16:30 | 3/6/26 | NUVL | Nuvalent, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Porter James Richard | MA | DO | P,CEO | S.d | -2,970 | 98.99 | 0 | -30 | -8 | 325 | D | | | | | | | | | | | | | | |
3/10/26 16:13 | 3/6/26 | SUPN | Supernus Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Khattar Jack A. | MD | DO | P,CEO | M.d | 0 | 0.00 | 0 | 39 | 2 | 2,234 | D | | | | | | | | | | | | | | |
3/10/26 16:13 | 3/6/26 | SUPN | Supernus Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mottola Frank | MD | O | SVP,Chie | M.d | 0 | 0.00 | 0 | 4 | 26 | 18 | D | | | | | | | | | | | | | | |
3/10/26 16:13 | 3/9/26 | SUPN | Supernus Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mottola Frank | MD | O | SVP,Chie | S.d | -87 | 53.65 | 0 | -2 | -8 | 18 | D | | | | | | | | | | | | | | |
3/10/26 16:12 | 3/6/26 | SUPN | Supernus Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dec Timothy C | MD | O | Senior V | M.d | 0 | 0.00 | 0 | 6 | 269 | 8 | D | | | | | | | | | | | | | | |
3/10/26 16:12 | 3/6/26 | SUPN | Supernus Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Horich William Todd | MD | O | SVP,Comm | M.d | 0 | 0.00 | 0 | 8 | | 0 | D | | | | | | | | | | | | | | |
3/10/26 16:12 | 3/9/26 | SUPN | Supernus Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Horich William Todd | MD | O | SVP,Comm | S.dm | -484 | 54.50 | 0 | -9 | -100 | 0 | D | | | | | | | | | | | | | | |
3/10/26 16:09 | 3/6/26 | ANIP | Ani Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Mutz Christopher | MN | O | HEAD OF | S.m | -425 | 74.19 | 0 | -6 | -6 | 94 | D | | | | | | | | | | | | | | |
3/10/26 16:08 | 3/6/26 | ZLAB | Zai Lab Ltd | E9 | Health | Drug | Pharmaceutical Preparations | Du Ying | MA | DO | Chairper | M.dm | 174 | 1.74 | 0 | 100 | 12 | 964 | D | | | | | | | | | | | | | | |
3/10/26 16:08 | 3/6/26 | ZLAB | Zai Lab Ltd | E9 | Health | Drug | Pharmaceutical Preparations | Du Ying | MA | DO | Chairper | S.dm | -1,922 | 19.22 | 0 | -100 | -9 | 964 | D | | | | | | | | | | | | | | |
3/10/26 16:06 | 3/6/26 | ANIP | Ani Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Davis Krista | MN | O | SVP,CHRO | S.m | -488 | 74.33 | 0 | -7 | -11 | 52 | D | | | | | | | | | | | | | | |
3/10/26 14:24 | 3/6/26 | PRGO | Perrigo Co Plc | L2 | Health | Drug | Pharmaceutical Preparations | Willis Robert | MI | O | EVP,CHRO | M.d | 48 | 10.72 | 0 | 5 | 10 | 48 | D | | | | | | | | | | | | | | |
3/10/26 14:01 | 3/6/26 | PRGO | Perrigo Co Plc | L2 | Health | Drug | Pharmaceutical Preparations | Lockwood-Taylor Patrick | MI | DO | CEO | M.d | 126 | 10.72 | 0 | 12 | 13 | 102 | D | | | | | | | | | | | | | | |
3/10/26 13:55 | 3/6/26 | PRGO | Perrigo Co Plc | L2 | Health | Drug | Pharmaceutical Preparations | Samuelson Jonas | MI | D | | M.d | 33 | 10.72 | 0 | 3 | | 1 | D | | | | | | | | | | | | | | |
3/10/26 11:49 | 3/6/26 | PRGO | Perrigo Co Plc | L2 | Health | Drug | Pharmaceutical Preparations | Bezerra Eduardo Guarita | MI | O | EVP,CFO | M.d | 106 | 10.72 | 0 | 10 | 16 | 73 | D | | | | | | | | | | | | | | |
3/9/26 20:18 | 3/5/26 | NAMS | Newamsterdam Pharma Co N.V. | P7 | Health | Drug | Pharmaceutical Preparations | Kastelein Johannes Jacob Pieter | P7 | DO | Chief Sc | M.dm | 0 | 0.00 | 0 | 300 | | 69 | I | | | | | | | | | | | | | | |
3/9/26 20:18 | 3/5/26 | NAMS | Newamsterdam Pharma Co N.V. | P7 | Health | Drug | Pharmaceutical Preparations | Kastelein Johannes Jacob Pieter | P7 | DO | Chief Sc | S.dm | -9,091 | 30.30 | 0 | -300 | -81 | 69 | I | | | | | | | | | | | | | | |
3/9/26 19:00 | 3/5/26 | ARWR | Arrowhead Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hamilton James C | CA | O | Chief Me | S | -642 | 64.19 | 0 | -10 | -4 | 237 | D | | | | | | | | | | | | | | |
3/9/26 18:12 | 3/4/25 | BHVN | Biohaven Ltd. | D8 | Health | Drug | Pharmaceutical Preparations | Childs John W | CT | D | | P.a | 864 | 30.43 | 0 | 28 | 1 | 2,397 | I | | | | | | | | | | | | | | |
3/9/26 17:15 | 3/9/26 | JAZZ | Jazz Pharmaceuticals Plc | L2 | Health | Drug | Pharmaceutical Preparations | Carr Patricia | L2 | O | SVP,Chie | S | -235 | 182.94 | 0 | -1 | -17 | 7 | D | | | | | | | | | | | | | | |
3/9/26 16:36 | 3/6/26 | UTHR | United Therapeutics Corp | DE | Health | Drug | Pharmaceutical Preparations | Olian Judy D. | MD | D | | S | -102 | 510.00 | 0 | 0 | -4 | 5 | D | | | | | | | | | | | | | | |
3/9/26 16:36 | 3/6/26 | LYEL | Lyell Immunopharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Arch Venture Partners Ix, LLC | IL | T | | P | 12,500 | 25.61 | 0 | 488 | 18 | 3,247 | I | | | | | | | | | | | | | | |
3/9/26 16:36 | 3/5/26 | UTHR | United Therapeutics Corp | DE | Health | Drug | Pharmaceutical Preparations | Rothblatt Martine A | MD | DO | CHAIRPER | M.d | 1,387 | 146.03 | 0 | 10 | 2 | 639 | D | | | | | | | | | | | | | | |
3/9/26 16:36 | 3/5/26 | UTHR | United Therapeutics Corp | DE | Health | Drug | Pharmaceutical Preparations | Rothblatt Martine A | MD | DO | CHAIRPER | S.d | -4,603 | 484.55 | 0 | -10 | -1 | 639 | D | | | | | | | | | | | | | | |
3/9/26 16:34 | 3/6/26 | LYEL | Lyell Immunopharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Arch Venture Fund Xiii, L.P. | IL | T | | P | 12,500 | 25.61 | 0 | 488 | 18 | 3,247 | I | | | | | | | | | | | | | | |
3/9/26 16:23 | 3/5/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Sabag Mark | L3 | O | See "Rem | M.d | 0 | 0.00 | 0 | 16 | 6 | 287 | D | | | | | | | | | | | | | | |
3/9/26 16:22 | 3/5/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Kalif Eliyahu Sharon | L3 | O | EVP,CFO | M.d | 0 | 0.00 | 0 | 20 | 7 | 325 | D | | | | | | | | | | | | | | |
3/9/26 16:19 | 3/5/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Weiss Amir | L3 | O | Chief Ac | M.d | 0 | 0.00 | 0 | 4 | 13 | 31 | D | | | | | | | | | | | | | | |
3/9/26 16:18 | 3/5/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Francis Richard D | L3 | O | P,CEO | M.d | 0 | 0.00 | 0 | 42 | 4 | 1,171 | D | | | | | | | | | | | | | | |
3/9/26 16:18 | 3/5/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Francis Richard D | L3 | O | P,CEO | S.d | -634 | 31.67 | 0 | -20 | -2 | 1,171 | D | | | | | | | | | | | | | | |
3/9/26 16:16 | 3/5/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fox Christine | L3 | O | EVP,U.S. | M.d | 0 | 0.00 | 0 | 18 | 27 | 85 | D | | | | | | | | | | | | | | |
3/9/26 16:16 | 3/5/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fox Christine | L3 | O | EVP,U.S. | S.d | -251 | 31.67 | 0 | -8 | -9 | 85 | D | | | | | | | | | | | | | | |
3/9/26 16:14 | 3/5/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Hughes Eric A | L3 | O | See "Rem | M.d | 0 | 0.00 | 0 | 20 | 22 | 108 | D | | | | | | | | | | | | | | |
3/9/26 16:14 | 3/5/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Hughes Eric A | L3 | O | See "Rem | S.d | -302 | 31.67 | 0 | -10 | -8 | 108 | D | | | | | | | | | | | | | | |
3/9/26 16:12 | 3/5/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Daniell Richard | L3 | O | EVP,Euro | M.d | 0 | 0.00 | 0 | 17 | 25 | 86 | D | | | | | | | | | | | | | | |
3/9/26 16:12 | 3/5/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Daniell Richard | L3 | O | EVP,Euro | S.d | -548 | 31.67 | 0 | -17 | -17 | 86 | D | | | | | | | | | | | | | | |
3/9/26 16:12 | 3/5/26 | AGIO | Agios Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Viswanadhan Krishnan | MA | O | Chief Co | M.d | 0 | 0.00 | 0 | 8 | | 5 | D | | | | | | | | | | | | | | |
3/9/26 16:12 | 3/5/26 | AGIO | Agios Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Viswanadhan Krishnan | MA | O | Chief Co | S.d | -82 | 27.80 | 0 | -3 | -37 | 5 | D | | | | | | | | | | | | | | |
3/9/26 16:10 | 3/5/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Jover Placid | L3 | O | See "Rem | M.d | 0 | 0.00 | 0 | 14 | | 7 | D | | | | | | | | | | | | | | |
3/9/26 16:10 | 3/5/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Jover Placid | L3 | O | See "Rem | S.d | -448 | 31.67 | 0 | -14 | -68 | 7 | D | | | | | | | | | | | | | | |
3/9/26 16:09 | 3/5/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Savage Brian | L3 | O | Interim | M.d | 0 | 0.00 | 0 | 4 | 49 | 11 | D | | | | | | | | | | | | | | |
3/9/26 16:09 | 3/5/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Savage Brian | L3 | O | Interim | S.d | -36 | 31.67 | 0 | -1 | -9 | 11 | D | | | | | | | | | | | | | | |
3/9/26 16:07 | 3/5/26 | RAPP | Rapport Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gault Cheryl | MA | O | COO | S | -58 | 28.93 | 0 | -2 | -1 | 170 | D | | | | | | | | | | | | | | |
3/9/26 16:07 | 3/5/26 | XNCR | Xencor Inc | DE | Health | Drug | Pharmaceutical Preparations | Desjarlais John R | CA | O | SVP,CSO | S.m | -74 | 11.16 | 0 | -7 | -2 | 264 | D | | | | | | | | | | | | | | |
3/9/26 16:06 | 3/5/26 | SUPN | Supernus Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gemayel Georges | MD | D | | S.dm | -1,003 | 53.38 | 0 | -19 | -41 | 27 | D | | | | | | | | | | | | | | |
3/9/26 16:06 | 3/6/26 | SUPN | Supernus Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gemayel Georges | MD | D | | M.d | 200 | 25.30 | 0 | 8 | 41 | 27 | D | | | | | | | | | | | | | | |
3/9/26 16:06 | 3/5/26 | XNCR | Xencor Inc | DE | Health | Drug | Pharmaceutical Preparations | Eckert Celia | CA | O | SVP,GC | S.m | -56 | 11.17 | 0 | -5 | -6 | 77 | D | | | | | | | | | | | | | | |
3/9/26 16:06 | 3/5/26 | XNCR | Xencor Inc | DE | Health | Drug | Pharmaceutical Preparations | Cornelissen Bart Jan | CA | O | SVP,CFO | S | -28 | 11.25 | 0 | -3 | -3 | 79 | D | | | | | | | | | | | | | | |
3/9/26 16:06 | 3/5/26 | XNCR | Xencor Inc | DE | Health | Drug | Pharmaceutical Preparations | Dahiyat Bassil I | CA | DO | P,CEO | S.m | -240 | 11.18 | 0 | -21 | -4 | 546 | D | | | | | | | | | | | | | | |
3/9/26 16:05 | 3/5/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Shields Matthew | L3 | O | EVP,Glob | M.d | 0 | 0.00 | 0 | 17 | | 10 | D | | | | | | | | | | | | | | |
3/9/26 16:05 | 3/5/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Shields Matthew | L3 | O | EVP,Glob | S.d | -548 | 31.67 | 0 | -17 | -63 | 10 | D | | | | | | | | | | | | | | |
3/9/26 16:05 | 3/6/26 | ARVN | Arvinas, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Morrison Briggs | CT | D | | P | 268 | 13.40 | 0 | 20 | 26 | 96 | D | | | | | | | | | | | | | | |
3/9/26 16:01 | 3/5/26 | TNGX | Tango Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Crystal Adam | MA | O | P,R,D | S | -304 | 15.00 | 0 | -20 | -15 | 113 | D | | | | | | | | | | | | | | |
3/9/26 07:05 | 3/6/26 | ALT | Altimmune, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Weaver Gregory L | MD | O | CFO | P | 18 | 3.54 | 0 | 5 | 22 | 28 | D | | | | | | | | | | | | | | |
3/9/26 07:00 | 3/6/26 | ALT | Altimmune, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Durso Jerome Benedict | MD | DO | P,CEO | P | 71 | 3.54 | 0 | 20 | 160 | 33 | D | | | | | | | | | | | | | | |
3/6/26 21:31 | 3/5/26 | BFRI | Biofrontera Inc. | DE | Health | Drug | Pharmaceutical Preparations | Luebbert Hermann | MA | DO | CEO,CB | M.d | 0 | 0.00 | 0 | 138 | 90 | 290 | D | | | | | | | | | | | | | | |
3/6/26 21:30 | 3/5/26 | BFRI | Biofrontera Inc. | DE | Health | Drug | Pharmaceutical Preparations | Leffler Eugene Frederick | MA | O | CFO | M.d | 0 | 0.00 | 0 | 88 | 100 | 175 | D | | | | | | | | | | | | | | |
3/6/26 19:27 | 3/4/26 | BCAX | Bicara Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mazumdar Claire | MA | DO | CEO | M.dm | 31 | 3.79 | 0 | 8 | 2 | 339 | D | | | | | | | | | | | | | | |
3/6/26 19:27 | 3/4/26 | BCAX | Bicara Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mazumdar Claire | MA | DO | CEO | S.dm | -154 | 18.74 | 0 | -8 | -2 | 339 | D | | | | | | | | | | | | | | |
3/6/26 19:18 | 3/6/26 | MDGL | Madrigal Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dier Mardi | PA | O | EVP,CFO | S.d | -854 | 430.87 | 0 | -2 | -14 | 12 | D | | | | | | | | | | | | | | |
3/6/26 18:56 | 3/5/26 | SION | Sionna Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Fitzpatrick Jennifer | MA | O | GC | M.d | 63 | 6.11 | 0 | 10 | | 0 | D | | | | | | | | | | | | | | |
3/6/26 18:56 | 3/5/26 | SION | Sionna Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Fitzpatrick Jennifer | MA | O | GC | S.d | -347 | 33.86 | 0 | -10 | -100 | 0 | D | | | | | | | | | | | | | | |
3/6/26 18:51 | 3/4/26 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Reardon Andrew | FL | O | CLO,Secr | M.d | 261 | 52.27 | 0 | 5 | 16 | 37 | D | | | | | | | | | | | | | | |
3/6/26 18:51 | 3/4/26 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Reardon Andrew | FL | O | CLO,Secr | S.d | -1,032 | 206.35 | 0 | -5 | -12 | 37 | D | | | | | | | | | | | | | | |
3/6/26 18:49 | 3/4/26 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Espinoza Octavio | FL | O | CFO | M.d | 132 | 63.49 | 0 | 2 | 11 | 22 | D | | | | | | | | | | | | | | |
3/6/26 18:49 | 3/4/26 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Espinoza Octavio | FL | O | CFO | S.d | -2,763 | 205.83 | 0 | -13 | -38 | 22 | D | | | | | | | | | | | | | | |
3/6/26 18:49 | 3/6/26 | MDGL | Madrigal Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Sibold William John | PA | DO | P,CEO | S.d | -718 | 431.94 | 0 | -2 | -1 | 162 | D | | | | | | | | | | | | | | |
3/6/26 18:34 | 3/6/26 | MDGL | Madrigal Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kelley Shannon T | PA | O | GC | S.d | -155 | 431.94 | 0 | 0 | -3 | 12 | D | | | | | | | | | | | | | | |
3/6/26 18:15 | 3/6/26 | MDGL | Madrigal Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Huntsman Carole | PA | O | Chief Co | S.d | -181 | 431.94 | 0 | 0 | -3 | 13 | D | | | | | | | | | | | | | | |
3/6/26 18:07 | 3/6/26 | MDGL | Madrigal Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Taub Rebecca | PA | D | | S | -212 | 431.94 | 0 | 0 | 0 | 1,108 | D | | | | | | | | | | | | | | |
3/6/26 17:29 | 3/5/26 | SDGR | Schrodinger, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Herman Jenny | NY | O | CAO | S.m | -18 | 12.84 | 0 | -1 | -4 | 35 | D | | | | | | | | | | | | | | |
3/6/26 17:29 | 3/5/26 | SDGR | Schrodinger, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Jain Rachit | NY | O | EVP,CFO | S | -21 | 12.90 | 0 | -2 | -3 | 53 | D | | | | | | | | | | | | | | |
3/6/26 17:28 | 3/5/26 | SDGR | Schrodinger, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Tran Yvonne | NY | O | EVP, CLO | S | -14 | 12.90 | 0 | -1 | -2 | 53 | D | | | | | | | | | | | | | | |
3/6/26 17:28 | 3/5/26 | SDGR | Schrodinger, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Farid Ramy | NY | DO | P,CEO | S | -47 | 12.91 | 0 | -4 | -1 | 331 | D | | | | | | | | | | | | | | |
3/6/26 17:27 | 3/5/26 | SDGR | Schrodinger, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Akinsanya Karen | NY | O | See Rema | S | -18 | 12.90 | 0 | -1 | -2 | 70 | D | | | | | | | | | | | | | | |
3/6/26 17:26 | 3/5/26 | SDGR | Schrodinger, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lorton Kenneth Patrick | NY | O | EVP,CTO, | S | -16 | 12.90 | 0 | -1 | -1 | 89 | D | | | | | | | | | | | | | | |
3/6/26 17:26 | 3/4/26 | SDGR | Schrodinger, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Abel Robert Lorne | NY | O | See Rema | S | -17 | 12.81 | 0 | -1 | -2 | 56 | D | | | | | | | | | | | | | | |
3/6/26 17:07 | 3/4/26 | QURE | Uniqure N.V. | | Health | Drug | Pharmaceutical Preparations | Kapusta Matthew C | P7 | DO | CEO,MD | S.d | -132 | 9.06 | 0 | -15 | -2 | 661 | D | | | | | | | | | | | | | | |
3/6/26 17:05 | 3/4/26 | ABBV | Abbvie Inc. | DE | Health | Drug | Pharmaceutical Preparations | Purdue David Ryan | IL | O | SVP,Cont | S | -1,222 | 233.56 | 0 | -5 | -62 | 3 | D | | | | | | | | | | | | | | |
3/6/26 17:01 | 3/5/26 | EDSA | Edesa Biotech, Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Nijhawan Pardeep | A6 | DOT | CEO | P | 39 | 3.90 | 0 | 10 | 1 | 1,148 | I | | | | | | | | | | | | | | |
3/6/26 16:59 | 3/4/26 | QURE | Uniqure N.V. | | Health | Drug | Pharmaceutical Preparations | Abi-Saab Walid | | O | Chief Me | S.d | -7 | 9.06 | 0 | -1 | 0 | 190 | D | | | | | | | | | | | | | | |
3/6/26 16:57 | 3/4/26 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ellis Andrea | CA | D | | M.d | 549 | 8.45 | 0 | 65 | | 19 | D | | | | | | | | | | | | | | |
3/6/26 16:57 | 3/4/26 | BBIO | Bridgebio Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ellis Andrea | CA | D | | S.d | -4,211 | 64.87 | 0 | -65 | -78 | 19 | D | | | | | | | | | | | | | | |
3/6/26 16:55 | 3/4/26 | GENB | Generate Biomedicines, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Nally Michael | MA | DO | CEO | P | 240 | 12.00 | 0 | 20 | 1 | 2,889 | D | | | | | | | | | | | | | | |
3/6/26 16:51 | 3/4/26 | RYTM | Rhythm Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | German Christopher Paul | MA | O | Corporat | M.d | 27 | 17.97 | 0 | 2 | | 0 | D | | | | | | | | | | | | | | |
3/6/26 16:51 | 3/4/26 | RYTM | Rhythm Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | German Christopher Paul | MA | O | Corporat | S.d | -503 | 89.56 | 0 | -6 | -97 | 0 | D | | | | | | | | | | | | | | |
3/6/26 16:36 | 3/4/26 | TRDA | Entrada Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wentworth Kory James | MA | O | CFO | S | -98 | 12.25 | 0 | -8 | -5 | 138 | D | | | | | | | | | | | | | | |
3/6/26 16:35 | 3/4/26 | QURE | Uniqure N.V. | | Health | Drug | Pharmaceutical Preparations | Potts Jeannette | | O | GC | S.d | -31 | 9.06 | 0 | -3 | -2 | 138 | D | | | | | | | | | | | | | | |
3/6/26 16:30 | 3/4/26 | CORT | Corcept Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Guyer William | CA | O | Chief De | M.d | 178 | 21.65 | 0 | 8 | | 2 | D | | | | | | | | | | | | | | |
3/6/26 16:30 | 3/4/26 | CORT | Corcept Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Guyer William | CA | O | Chief De | S.d | -296 | 35.99 | 0 | -8 | -79 | 2 | D | | | | | | | | | | | | | | |
3/6/26 16:30 | 3/4/26 | QURE | Uniqure N.V. | | Health | Drug | Pharmaceutical Preparations | Klemt Christian | P7 | O | CFO | S.d | -109 | 9.06 | 0 | -12 | -5 | 227 | D | | | | | | | | | | | | | | |
3/6/26 16:26 | 3/5/26 | ZLAB | Zai Lab Ltd | E9 | Health | Drug | Pharmaceutical Preparations | Edmondson Frazor Titus III | MA | O | GC | S | -297 | 19.06 | 0 | -16 | -82 | 4 | D | | | | | | | | | | | | | | |
3/6/26 16:25 | 3/4/26 | ZLAB | Zai Lab Ltd | E9 | Health | Drug | Pharmaceutical Preparations | Du Ying | MA | DO | Chairper | M.dm | 174 | 1.74 | 0 | 100 | 12 | 964 | D | | | | | | | | | | | | | | |
3/6/26 16:25 | 3/4/26 | ZLAB | Zai Lab Ltd | E9 | Health | Drug | Pharmaceutical Preparations | Du Ying | MA | DO | Chairper | S.dm | -1,919 | 19.19 | 0 | -100 | -9 | 964 | D | | | | | | | | | | | | | | |
3/6/26 16:19 | 3/4/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Francis Richard D | L3 | O | P,CEO | M.d | 0 | 0.00 | 0 | 50 | 5 | 1,148 | D | | | | | | | | | | | | | | |
3/6/26 16:19 | 3/4/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Francis Richard D | L3 | O | P,CEO | S.d | -759 | 32.46 | 0 | -23 | -2 | 1,148 | D | | | | | | | | | | | | | | |
3/6/26 16:17 | 3/4/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Daniell Richard | L3 | O | EVP,Euro | M.d | 0 | 0.00 | 0 | 54 | 170 | 86 | D | | | | | | | | | | | | | | |
3/6/26 16:17 | 3/4/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Daniell Richard | L3 | O | EVP,Euro | S.d | -2,984 | 32.66 | 0 | -91 | -52 | 86 | D | | | | | | | | | | | | | | |
3/6/26 16:14 | 3/4/26 | PEPG | Pepgen Inc. | DE | Health | Drug | Pharmaceutical Preparations | Streck Paul | MA | O | EVP,Head | S | -12 | 6.23 | 0 | -2 | -2 | 76 | D | | | | | | | | | | | | | | |
3/6/26 16:13 | 3/4/26 | ALNY | Alnylam Pharmaceuticals, Inc. | | Health | Drug | Pharmaceutical Preparations | Garg Pushkal | MA | O | EVP Chie | S.m | -1,525 | 323.53 | 0 | -5 | -20 | 19 | D | | | | | | | | | | | | | | |
3/6/26 16:13 | 3/4/26 | ALNY | Alnylam Pharmaceuticals, Inc. | | Health | Drug | Pharmaceutical Preparations | Greenstreet Yvonne | MA | DO | CEO | S | -948 | 323.08 | 0 | -3 | -3 | 96 | D | | | | | | | | | | | | | | |
3/6/26 16:13 | 3/4/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Sabag Mark | L3 | O | See "Rem | M.d | 0 | 0.00 | 0 | 52 | 24 | 271 | D | | | | | | | | | | | | | | |
3/6/26 16:12 | 3/4/26 | ALNY | Alnylam Pharmaceuticals, Inc. | | Health | Drug | Pharmaceutical Preparations | Poulton Jeffrey V. | MA | O | EVP,CFO | S | -797 | 323.08 | 0 | -2 | -4 | 62 | D | | | | | | | | | | | | | | |
3/6/26 16:12 | 3/4/26 | ALNY | Alnylam Pharmaceuticals, Inc. | | Health | Drug | Pharmaceutical Preparations | Tanguler Tolga | MA | O | EVP,Chie | S | -746 | 323.08 | 0 | -2 | -6 | 34 | D | | | | | | | | | | | | | | |
3/6/26 16:12 | 3/4/26 | PEPG | Pepgen Inc. | DE | Health | Drug | Pharmaceutical Preparations | Donnelly Noel | MA | O | CFO | S | -13 | 6.23 | 0 | -2 | -2 | 112 | D | | | | | | | | | | | | | | |
3/6/26 16:11 | 3/4/26 | ALNY | Alnylam Pharmaceuticals, Inc. | | Health | Drug | Pharmaceutical Preparations | Fitzgerald Kevin Joseph | MA | O | CSO,EVP, | S.m | -418 | 323.54 | 0 | -1 | -6 | 21 | D | | | | | | | | | | | | | | |
3/6/26 16:10 | 3/5/26 | DYN | Dyne Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Friedl-Naderer Johanna | MA | O | Chief Co | S | -2 | 14.90 | 0 | 0 | 0 | 155 | D | | | | | | | | | | | | | | |
3/6/26 16:09 | 3/4/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Hughes Eric A | L3 | O | See "Rem | M.d | 0 | 0.00 | 0 | 23 | 31 | 98 | D | | | | | | | | | | | | | | |
3/6/26 16:09 | 3/4/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Hughes Eric A | L3 | O | See "Rem | S.d | -366 | 32.46 | 0 | -11 | -10 | 98 | D | | | | | | | | | | | | | | |
3/6/26 16:09 | 3/4/26 | PEPG | Pepgen Inc. | DE | Health | Drug | Pharmaceutical Preparations | McArthur James G | MA | DO | P,CEO | S | -33 | 6.23 | 0 | -5 | -2 | 296 | D | | | | | | | | | | | | | | |
3/6/26 16:09 | 3/5/26 | DYN | Dyne Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kerr Douglas | MA | O | Chief Me | S | -13 | 14.90 | 0 | -1 | -1 | 172 | D | | | | | | | | | | | | | | |
3/6/26 16:08 | 3/4/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Kalif Eliyahu Sharon | L3 | O | EVP,CFO | M.d | 0 | 0.00 | 0 | 57 | 23 | 306 | D | | | | | | | | | | | | | | |
3/6/26 16:08 | 3/5/26 | DYN | Dyne Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cox John | MA | DO | CEO,P | S | -41 | 14.90 | 0 | -3 | -1 | 446 | D | | | | | | | | | | | | | | |
3/6/26 16:05 | 3/4/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fox Christine | L3 | O | EVP,U.S. | M.d | 0 | 0.00 | 0 | 20 | 38 | 75 | D | | | | | | | | | | | | | | |
3/6/26 16:05 | 3/4/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Fox Christine | L3 | O | EVP,U.S. | S.d | -295 | 32.46 | 0 | -9 | -11 | 75 | D | | | | | | | | | | | | | | |
3/6/26 16:05 | 3/4/26 | VRTX | Vertex Pharmaceuticals Inc / Ma | MA | Health | Drug | Pharmaceutical Preparations | McKechnie Duncan | MA | O | EVP,Chie | S | -1,158 | 475.30 | 0 | -2 | -14 | 15 | D | | | | | | | | | | | | | | |
3/6/26 16:03 | 3/4/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Savage Brian | L3 | O | Interim | M.d | 0 | 0.00 | 0 | 8 | 999% | 8 | D | | | | | | | | | | | | | | |
3/6/26 16:03 | 3/4/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Savage Brian | L3 | O | Interim | S.d | -87 | 32.46 | 0 | -3 | -24 | 8 | D | | | | | | | | | | | | | | |
3/6/26 16:01 | 3/4/26 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Weiss Amir | L3 | O | Chief Ac | M.d | 0 | 0.00 | 0 | 16 | 151 | 27 | D | | | | | | | | | | | | | | |
3/6/26 09:00 | 3/4/26 | ERAS | Erasca, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Morris Shannon | CA | O | Chief Me | M.d | 34 | 1.70 | 0 | 20 | | 0 | D | | | | | | | | | | | | | | |
3/6/26 09:00 | 3/4/26 | ERAS | Erasca, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Morris Shannon | CA | O | Chief Me | S.d | -301 | 15.04 | 0 | -20 | -100 | 0 | D | | | | | | | | | | | | | | |
3/6/26 07:28 | 3/5/26 | PMN | Promis Neurosciences Inc. | Z4 | Health | Drug | Pharmaceutical Preparations | Williams Eugene | A6 | D | | P | 49 | 24.40 | 0 | 2 | 19 | 12 | D | | | | | | | | | | | | | | |
3/5/26 20:00 | 3/3/26 | OLMA | Olema Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mitchell Shawnte | CA | O | GC | M.dm | 175 | 4.37 | 0 | 40 | | 0 | D | | | | | | | | | | | | | | |
3/5/26 20:00 | 3/3/26 | OLMA | Olema Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mitchell Shawnte | CA | O | GC | S.dm | -952 | 23.79 | 0 | -40 | -99 | 0 | D | | | | | | | | | | | | | | |
3/5/26 19:18 | 3/5/26 | XERS | Xeris Biopharma Holdings, Inc. | | Health | Drug | Pharmaceutical Preparations | Pieper Steven | IL | O | See Rema | M.d | 197 | 4.71 | 0 | 42 | 3 | 1,409 | D | | | | | | | | | | | | | | |
3/5/26 19:10 | 3/3/26 | BCAX | Bicara Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cohlhepp Ryan | MA | DO | P,COO | M.d | 49 | 3.79 | 0 | 13 | 7 | 205 | D | | | | | | | | | | | | | | |
3/5/26 19:10 | 3/3/26 | BCAX | Bicara Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cohlhepp Ryan | MA | DO | P,COO | S.d | -316 | 18.16 | 0 | -17 | -8 | 205 | D | | | | | | | | | | | | | | |
3/5/26 19:08 | 3/3/26 | BCAX | Bicara Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hyep Ivan | MA | O | CFO | M.dm | 63 | 3.79 | 0 | 17 | 13 | 145 | D | | | | | | | | | | | | | | |
3/5/26 19:08 | 3/3/26 | BCAX | Bicara Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hyep Ivan | MA | O | CFO | S.dm | -301 | 18.22 | 0 | -17 | -10 | 145 | D | | | | | | | | | | | | | | |
3/5/26 19:06 | 3/3/26 | BCAX | Bicara Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Raben David | MA | O | Chief Me | M.dm | 63 | 3.79 | 0 | 17 | 43 | 55 | D | | | | | | | | | | | | | | |
3/5/26 19:06 | 3/3/26 | BCAX | Bicara Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Raben David | MA | O | Chief Me | S.dm | -306 | 18.52 | 0 | -17 | -23 | 55 | D | | | | | | | | | | | | | | |
3/5/26 19:00 | 3/4/26 | VTRS | Viatris Inc | DE | Health | Drug | Pharmaceutical Preparations | Mistras Theodora | PA | O | CFO | M.d | 0 | 0.00 | 0 | 34 | 201 | 51 | D | | | | | | | | | | | | | | |
3/5/26 19:00 | 3/4/26 | VTRS | Viatris Inc | DE | Health | Drug | Pharmaceutical Preparations | Le Goff Corinne | PA | O | Chief Co | M.d | 0 | 0.00 | 0 | 40 | 225 | 57 | D | | | | | | | | | | | | | | |
3/5/26 19:00 | 3/3/26 | VTRS | Viatris Inc | DE | Health | Drug | Pharmaceutical Preparations | Enrietti Andrew | PA | O | See Rema | M.d | 0 | 0.00 | 0 | 111 | 113 | 208 | D | | | | | | | | | | | | | | |
3/5/26 19:00 | 3/3/26 | VTRS | Viatris Inc | DE | Health | Drug | Pharmaceutical Preparations | Campbell Paul | PA | O | See Rema | M.dm | 0 | 0.00 | 0 | 209 | 128 | 372 | D | | | | | | | | | | | | | | |
3/5/26 19:00 | 3/3/26 | VTRS | Viatris Inc | DE | Health | Drug | Pharmaceutical Preparations | Smith Scott Andrew | PA | DO | CEO | M.dm | 0 | 0.00 | 0 | 1,542 | | 1,250 | D | | | | | | | | | | | | | | |
3/5/26 18:55 | 3/4/26 | AKBA | Akebia Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Butler John P. | MA | DO | CEO,P | P | 87 | 1.25 | 0 | 69 | 2 | 3,527 | D | | | | | | | | | | | | | | |
3/5/26 18:55 | 3/3/26 | ANTX | An2 Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Williams Sarah Joanne | CA | O | Principa | S | 0 | 1.06 | 0 | 0 | 0 | 67 | D | | | | | | | | | | | | | | |
3/5/26 18:14 | 3/3/26 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Loscalzo Joseph | CA | D | | M.dm | 39 | 38.06 | 0 | 1 | 3 | 36 | D | | | | | | | | | | | | | | |
3/5/26 18:14 | 3/3/26 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Loscalzo Joseph | CA | D | | S.dm | -83 | 80.26 | 0 | -1 | -3 | 36 | D | | | | | | | | | | | | | | |
3/5/26 18:14 | 3/3/26 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Klein Joseph III | CA | D | | M.d | 652 | 40.76 | 0 | 16 | | 11 | D | | | | | | | | | | | | | | |
3/5/26 18:14 | 3/3/26 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Klein Joseph III | CA | D | | S.d | -1,696 | 79.51 | 0 | -21 | -66 | 11 | D | | | | | | | | | | | | | | |
3/5/26 18:14 | 3/3/26 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Diaz Allene M. | CA | D | | M.d | 1,602 | 39.72 | 0 | 40 | | 4 | D | | | | | | | | | | | | | | |
3/5/26 18:14 | 3/3/26 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Diaz Allene M. | CA | D | | S.d | -4,354 | 79.35 | 0 | -55 | -94 | 4 | D | | | | | | | | | | | | | | |
3/5/26 18:14 | 3/3/26 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Devers Shannon L. | CA | O | EVP,Chie | M.d | 723 | 35.97 | 0 | 20 | 826 | 23 | D | | | | | | | | | | | | | | |
3/5/26 18:14 | 3/3/26 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Devers Shannon L. | CA | O | EVP,Chie | S.d | -1,596 | 79.40 | 0 | -20 | -47 | 23 | D | | | | | | | | | | | | | | |
3/5/26 18:13 | 3/3/26 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Bennett C Frank | CA | O | EVP,Chie | M.d | 3,498 | 53.73 | 0 | 65 | 421 | 81 | D | | | | | | | | | | | | | | |
3/5/26 18:13 | 3/3/26 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Bennett C Frank | CA | O | EVP,Chie | S.d | -6,742 | 79.23 | 0 | -85 | -51 | 81 | D | | | | | | | | | | | | | | |
3/5/26 18:13 | 3/3/26 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Baroldi Joseph | CA | O | EVP,Chie | S.dm | -531 | 79.74 | 0 | -7 | -13 | 46 | M | | | | | | | | | | | | | | |
3/5/26 18:13 | 3/3/26 | IONS | Ionis Pharmaceuticals Inc | CA | Health | Drug | Pharmaceutical Preparations | Baroldi Joseph | CA | O | EVP,Chie | M.dm | 95 | 44.57 | 0 | 2 | 5 | 46 | M | | | | | | | | | | | | | | |
3/5/26 17:46 | 3/5/26 | ANIP | Ani Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Carey Stephen P. | MN | O | SVP,CFO | M.d | 164 | 49.51 | 0 | 3 | 2 | 186 | D | | | | | | | | | | | | | | |
3/5/26 17:46 | 3/5/26 | ANIP | Ani Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Carey Stephen P. | MN | O | SVP,CFO | S.d | -552 | 75.50 | 0 | -7 | -4 | 186 | D | | | | | | | | | | | | | | |
3/5/26 17:01 | 3/4/26 | EDSA | Edesa Biotech, Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Nijhawan Pardeep | A6 | DOT | CEO | P | 43 | 4.26 | 0 | 10 | 1 | 1,138 | I | | | | | | | | | | | | | | |
3/5/26 16:52 | 3/3/26 | AMRX | Amneal Pharmaceuticals, Inc. | | Health | Drug | Pharmaceutical Preparations | Patel Chintu | NJ | DO | Co-CEO | M.dm | 0 | 0.00 | 0 | 886 | 4 | 26,142 | D | | | | | | | | | | | | | | |